Fosamax (or Alendronate) is an oral medication used to treat osteoporosis—the weakening and thinning of bones due to hormonal changes—in woman and men. Alendronates work by preventing bone decomposition and restore bone density. The medication Fosamax was sold by Merck, and was later created in generic form, certified by the U.S. Food and Drug Administration (FDA). Generic versions of Fosamax have been made by Apotex, Barr, Cobalt, Dr. Reddy’s, Mylan, Teva, and Watson.
Recently, Fosamax has been connected with many side effects including fractures of the femur; osteonecrosi—deterioration of the Temporomadibular Joint (TMJ)—primarily in patients with cancer, cancer of the esophagus, cardiac arrhythmias, and severe musculoskeletal pain. In 2000, the FDA required the manufacturers to issue a warning of the potential risks associated with Fosamax.
If you or someone in your family has suffered a serious injury or death after being prescribed Fosamax, you may be entitled to file a lawsuit and receive compensation. Please contact us toll free at 1-800-872-5925 to speak with our office regarding your case.